Cannabinoid formulations and delivery systems: Current and future options to treat pain

B Stella, F Baratta, C Della Pepa, S Arpicco, D Gastaldi… - Drugs, 2021 - Springer
The field of Cannabis sativa L. research for medical purposes has been rapidly advancing in
recent decades and a growing body of evidence suggests that phytocannabinoids are …

Promising nanocarriers to enhance solubility and bioavailability of cannabidiol for a plethora of therapeutic opportunities

L Grifoni, G Vanti, R Donato, C Sacco, AR Bilia - Molecules, 2022 - mdpi.com
In recent years, the interest in cannabidiol (CBD) has increased because of the lack of
psychoactive properties. However, CBD has low solubility and bioavailability, variable …

[HTML][HTML] Citrus limon L.(lemon) seed extract shows neuro-modulatory activity in an in vivo thiopental-sodium sleep model by reducing the sleep onset and enhancing …

MM Rahman, F Islam, A Parvez, MAK Azad… - Journal of Integrative …, 2022 - imrpress.com
Citrus limon L. is an ingenious alternative medication and has a broad scope in managing
several health conditions as part of natural remedies. Recently, medicinal plants have …

Neuropharmacological and Antidiabetic Potential of Lannea coromandelica (Houtt.) Merr. Leaves Extract: An Experimental Analysis

F Islam, S Mitra, MH Nafady… - Evidence‐Based …, 2022 - Wiley Online Library
The present study examines the neuropharmacological and antidiabetic properties of
methanol leaves extract of Lannea coromandelica in animal models. This study is carried …

Emerging therapeutic potential of cannabidiol (CBD) in neurological disorders: a comprehensive review

K Singh, B Bhushan, DK Chanchal… - Behavioural …, 2023 - Wiley Online Library
Cannabidiol (CBD), derived from Cannabis sativa, has gained remarkable attention for its
potential therapeutic applications. This thorough analysis explores the increasing …

Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis …

R Rifkin-Zybutz, S Erridge, C Holvey, R Coomber… - …, 2023 - Springer
Rationale Cannabis-based medicinal products (CBMPs) have been identified as novel
therapeutics for generalised anxiety disorder (GAD) based on pre-clinical models; however …

Delivering therapeutic cannabinoids via skin: Current state and future perspectives

AO Tijani, D Thakur, D Mishra, D Frempong… - Journal of Controlled …, 2021 - Elsevier
Adequate evidence exists in the literature indicating a relatively positive shift with regards to
the legal acceptance of cannabis and cannabis-derived products for medicinal purposes in …

Anti-inflammatory and antiviral effects of cannabinoids in inhibiting and preventing SARS-CoV-2 infection

M Janecki, M Graczyk, AA Lewandowska… - International journal of …, 2022 - mdpi.com
The COVID-19 pandemic caused by the SARS-CoV-2 virus made it necessary to search for
new options for both causal treatment and mitigation of its symptoms. Scientists and …

The therapeutic potential of purified cannabidiol

SE O'Sullivan, SS Jensen, GN Nikolajsen… - Journal of Cannabis …, 2023 - Springer
The use of cannabidiol (CBD) for therapeutic purposes is receiving considerable attention,
with speculation that CBD can be useful in a wide range of conditions. Only one product, a …

[HTML][HTML] Cannabinoid therapeutics in chronic neuropathic pain: from animal research to human treatment

RMP Campos, AFL Aguiar, Y Paes-Colli… - Frontiers in …, 2021 - frontiersin.org
Despite the importance of pain as a warning physiological system, chronic neuropathic pain
is frequently caused by damage in the nervous system, followed by persistence over a long …